- Home
- DVA vs CFR Comparison
DVA vs CFR Comparison
Compare DVA & CFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DVA | CFR |
|---|---|---|
| Founded | 1994 | 1868 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Misc Health and Biotechnology Services | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.1B | 8.1B |
| IPO Year | 2002 | N/A |
Fundamental Metrics
Financial Performance| Metric | DVA | CFR |
|---|---|---|
| Price | $150.71 | $131.90 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 4 | 13 |
| Target Price | ★ $156.75 | $143.08 |
| AVG Volume (30 Days) | ★ 797.3K | 544.2K |
| Earning Date | 05-04-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.01% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 9.84 | N/A |
| Revenue | ★ $13,643,069,000.00 | N/A |
| Revenue This Year | $3.80 | $9.72 |
| Revenue Next Year | $3.04 | $4.70 |
| P/E Ratio | $15.57 | ★ $14.55 |
| Revenue Growth | ★ 6.46 | N/A |
| 52 Week Low | $101.00 | $100.31 |
| 52 Week High | $159.42 | $148.97 |
Technical Indicators
Market Signals| Indicator | DVA | CFR |
|---|---|---|
| Relative Strength Index (RSI) | 57.20 | 31.04 |
| Support Level | $146.00 | $124.76 |
| Resistance Level | $150.69 | $146.95 |
| Average True Range (ATR) | 4.81 | 3.25 |
| MACD | -1.40 | -1.24 |
| Stochastic Oscillator | 34.35 | 9.65 |
Price Performance
Historical ComparisonAbout DVA DaVita Inc.
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
About CFR Cullen/Frost Bankers Inc.
Cullen/Frost is a regional US bank with around $53 billion in assets (as of September 2025), and it focuses exclusively on the Texas market. The bank has deep expertise in this market. It has implemented a relationship-based approach to banking that has garnered a strong market share in San Antonio. Cullen/Frost is also expanding into Houston, Dallas, and Austin market regions through branch openings. The bank's sweet spot is small to medium-size Texas-based commercial clients.